Cardiovascular pharmacology and therapeutics:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York [u.a.]
Churchill Livingstone
1994
|
| Ausgabe: | 1. publ. |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XX, 1231 S. Ill., graph. Darst. |
| ISBN: | 0443088144 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV009298461 | ||
| 003 | DE-604 | ||
| 005 | 20161006 | ||
| 007 | t | ||
| 008 | 940331s1994 ad|| |||| 00||| eng d | ||
| 020 | |a 0443088144 |9 0-443-08814-4 | ||
| 035 | |a (OCoLC)28748905 | ||
| 035 | |a (DE-599)BVBBV009298461 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-578 | ||
| 050 | 0 | |a RM345 | |
| 082 | 0 | |a 615/.71 |2 20 | |
| 084 | |a XI 4300 |0 (DE-625)153005:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Cardiovascular pharmacology and therapeutics |c ed. by Bramah N. Singh ... |
| 250 | |a 1. publ. | ||
| 264 | 1 | |a New York [u.a.] |b Churchill Livingstone |c 1994 | |
| 300 | |a XX, 1231 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 2 | |a Agents cardiovasculaires - Pharmacologie | |
| 650 | 2 | |a Agents cardiovasculaires - usage thérapeutique | |
| 650 | 7 | |a Farmacologie |2 gtt | |
| 650 | 7 | |a Farmacotherapie |2 gtt | |
| 650 | 7 | |a Hartziekten |2 gtt | |
| 650 | 2 | |a Maladies cardiovasculaires - Traitement médicamenteux | |
| 650 | 2 | |a Maladies cardiovasculaires - physiopathologie | |
| 650 | 4 | |a Cardiovascular Agents |x pharmacology | |
| 650 | 4 | |a Cardiovascular Agents |x therapeutic use | |
| 650 | 4 | |a Cardiovascular Diseases |x drug therapy | |
| 650 | 4 | |a Cardiovascular Diseases |x physiopathology | |
| 650 | 4 | |a Cardiovascular agents | |
| 650 | 4 | |a Heart |x Diseases |x Treatment | |
| 650 | 0 | 7 | |a Kardiovaskuläres System |0 (DE-588)4024665-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Kardiovaskuläres System |0 (DE-588)4024665-6 |D s |
| 689 | 0 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Singh, Bramah N. |e Sonstige |0 (DE-588)143174428 |4 oth | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006187495&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-006187495 | ||
Datensatz im Suchindex
| _version_ | 1804123739571355648 |
|---|---|
| adam_text | CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS EDITED BY BRAMAH N. SINGH,
M.D., D.PHIL., F.R.C.P. PROFESSOR DIVISION OF CARDIOLOGY, DEPARTMENT OF
MEDICINE UNIVERSITY OF CALIFORNIA, LOS ANGELES UCLA SCHOOL OF MEDICINE
CHIEF DIVISION OF CARDIOLOGY, DEPARTMENT OF MEDICINE WEST LOS ANGELES
VETERANS AFFAIRS MEDICAL CENTER LOS PAUL M. VANHOUTTE, M.D., PH.D. VICE
PRESIDENT FOR RESEARCH SENDER RESEARCH INSTITUTE COURBEVOIE, FRANCE NEW
YORK, VICTOR J. DZAU, M.D. WILLIAM G. IRWIN PROFESSOR OF MEDICINE CHIEF
DIVISION OF CARDIOVASCULAR MEDICINE DEPARTMENT OF MEDICINE STANFORD
UNIVERSITY SCHOOL OF MEDICINE STANFORD, CALIFORNIA RAYMOND L. WOOSLEY,
M.D., PH.D. PROFESSOR DEPARTMENTS OF MEDICINE AND PHARMACOLOGY CHAIRMAN
DEPARTMENT OF PHARMACOLOGY GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE
DIRECTOR DIVISION OF CLINICAL PHARMACOLOGY DEPARTMENT OF MEDICINE
GEORGETOWN UNIVERSITY HOSPITAL WASHINGTON, D.C. RRR *MI CHURCHILL
LIVINGSTONE EDINBURGH, LONDON, MADRID, MELBOURNE, TOKYO CONTENTS I.
FUNDAMENTAL CONCEPTS IN CARDIOVASCULAR DRUG ACTION AND THERAPY 1.
MECHANISMS OF DRUG ACTION 1 KEITH J. MORRISON AND PAUL M. VANHOUTTE 2.
SIGNIFICANCE OF PHARMACOKINETIC PRINCIPLES 15 S.L. SCHWARTZ, A.
WELLSTEIN, AND RAYMOND L. WOOSLEY 3. ROLE OF CONTROLLED CLINICAL TRIALS
IN DRUG EVALUATION 31 JANET WITTES AND BRAMAH N. SINGH 4. GENE THERAPY
AS POTENTIAL TREATMENT FOR CARDIOVASCULAR DISEASES 51 RYUICHI MORISHITA,
GARY H. GIBBONS, AND VICTOR J. DZAU //. PRINCIPAL CLASSES OF THERAPEUTIC
AGENTS: PRESENT AND FUTURE 5. SYMPATHOMIMETIC AMINES AND DOPAMINE
RECEPTOR AGONISTS 63 S.E. O CONNOR AND S.Z. LANGER 6. (3-ADRENOCEPTOR
BLOCKING DRUGS 85 J.D. FITZGERALD AND BRAMAH N. SINGH 7. A- ADRENERGIC
BLOCKING AGENTS 113 P.A. VAN ZWIETEN 8. DRUGS ACTING OH CHOLINERGIC
RECEPTORS 125 GAETANO M. DE FERRARI AND ANTONIO ZAZA 9. DRUGS ACTING ON
PURINERGIC RECEPTORS 145 M.G. COLLIS, C.J. BOWMER, AND M.S. YATES 10.
CORONARY ARTERIAL DILATORS AND VENODILATORS 163 EBERHARD BASSENGE 11.
DIRECT-ACTING VASODILATORS 173 KAUSHIK D. MEISHERI 12. CALCIUM
ANTAGONISTS 185 DAGNOVAR ARISTIZABAL AND EDWARD D. FROHLICH 13. SINUS
NODE INHIBITORS 203 CHRISTIAN LILLIE AND BRAMAH N. SINGH 14. SPECIFIC
METABOLICALLY ACTIVE ANTI- ISCHEMIC AGENTS: ADENOSINE AND NUCLEOSIDE
TRANSPORT INHIBITORS 217 HERMAN VAN BELLE 15. CARDIOVASCULAR
PHARMACOLOGY OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS 237 VICTOR J.
DZAU AND RICHARD E. PRATT XVII XVIII CONTENTS 16. ANTIARRHYTHMIC AGENTS:
MECHANISMS AND CLASSIFICATION 249 STANLEY NATTEL AND BRAMAH N. SINGH 17.
THROMBOLYTIC AGENTS 267 D. COLLEN AND H.R. LIJNEN 18. ANTICOAGULANTS 281
PAULETTE MEHTA AND JAWAHAR L. MEHTA 19. PLATELET-ACTIVE DRUGS 299 JAMES
H. CHESEBRO, JUAN J. BADIMON, BERNARDO STEIN, AND VALENTIN FUSTER 20.
NOVEL DRUG TARGETS IN VASCULAR PATHOBIOLOGY 317 VICTOR J. DZAU, GARY H.
GIBBONS, AND PHILIP C. LEE 21. INOTROPIC AGENTS 325 RANDALL E. WILLIAMS
AND ARTHUR M. FELDMAN 22. DIGITALIS 343 FRANK I. MARCUS 23. DIURETICS
353 RAJIV AGARWAL AND C. VENKATA S. RAM 24. HYPOLIPIDEMIC AGENTS 369
RODOLFO PAOLETTI AND FRANCO BERNINI 25. SEROTONIN RECEPTOR AGONISTS AND
ANTAGONISTS 385 HANS O. KALKMAN AND DANIEL HOYER 28. CALCIUM CHANNEL
BLOCKERS AS ANTI- ISCHEMIC AGENTS 425 GABRIEL B. HABIB AND ROBERT
ROBERTS 29. NITRATES AS ANTI-ISCHEMIC AND CARDIOPROTECTIVE AGENTS 449
BODH I. JUGDUTT IV. ACUTE MYOCARDIAL INFARCTION 30. PATHOGENESIS AND
PHARMACOLOGIC MANAGEMENT OF MYOCARDIAL INFARCTION 467 ROBIN N. NORRIS
AND BRAMAH N. SINGH 31. PRINCIPLES OF THROMBOLYTIC THERAPY IN MYOCARDIAL
INFARCTION 481 JOSEPH M. SUTTON AND ERIC J. TOPOL 32.
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION
499 GERVASIO A. LAMAS AND MARC A. PFEFFER 33. EFFECTS OF (3-BLOCKERS ON
CARDIOVASCULAR MORBIDITY AND MORTALITY IN CORONARY ARTERY DISEASE 511
J.D. FITZGERALD AND BRAMAH N. SINGH 34. IMPACT OF CALCIUM CHANNEL
BLOCKERS ON MORTALITY 525 PETER H. HELD AND SALIM YUSUF 35.
PLATELET-ACTIVE DRUGS AND MORTALITY REDUCTION 535 JOHN A. CAIRNS ///.
MYOCARDIAL ISCHEMIA AND INFARCTION I 26. PATHOGENESIS AND OVERVIEW OF
MYOCARDIAL ISCHEMIC SYNDROMES 399 H. VERNON ANDERSON AND JAMES T.
WILLERSON 27. ANTI-ISCHEMIC EFFECTS OF P-BLOCKERS 407 FRENY VAGHAIWALLA
MODY AND BRAMAH N. SINGH V. ANTITHROMBOTIC THERAPY IN THE PROPHYLAXIS OF
ARTERIAL THROMBOEMBOLISM 36. ASPIRIN AND DIPYRIDAMOLE 551 IK-KYUNG JANG
AND VALENTIN FUSTER 37. PREVENTING SYSTEMIC EMBOLIZATION IN PATIENTS
WITH CARDIAC DISEASE 561 MICHAEL D. EZEKOWITZ CONTENTS XIX VI. DISORDERS
OF CARDIAC RHYTHM 38. MECHANISMS OF CARDIAC ARRHYTHMIAS 585 CYNTHIA JECK
AND MICHAEL R. ROSEN 39. PHARMACOLOGIC THERAPY IN CARDIAC ARRHYTHMIAS
595 PRINCIPLES AND BACKGROUND CONSIDERATIONS 595 MICHAEL R. FRANZ,
BETTINA KOLLER, AND RAYMOND L. WOOSLEY OYERVIEW OF ANTIARRHYTHMIC DRUG
THERAPY 617 BRAMAH N. SINGH 40. OVERVIEW OF ANTIARRHYTHMIC DRUG TRIALS:
IMPLICATIONS FOR ANTIARRHYTHMIC THERAPY 631 KOON K. TEO AND SALIM YUSUF
41. SODIUM CHANNEL BLOCKERS TERENCE J. CAMPBELL 645 42. THE USE OF
P-ADRENOCEPTOR BLOCKING DRUGS AS ANTIARRHYTHMIC AGENTS 665 AURELIO DURAN
AND ROBERT J. MYERBURG 43. POTASSIUM CHANNEL BLOCKERS AS ANTIARRHYTHMIC
AGENTS 675 THOMAS J. COLATSKY AND BRAMAH N. SINGH 44. AMIODARONE AND
AMIODARONE DERIVATIVES 689 BRAMAH N. SINGH AND JONNALAGEDDA S.M. SARMA
45. ADRENERGIC NEURON BLOCKERS AS CLASS III ANTIARRHYTHMIC AGENTS:
BRETYLIUM AND ITS ANALOGS 711 JEFFREY L. ANDERSON 46. SOTALOL AND
D-SOTALOL IN THE CONTROL OF CARDIAC ARRHYTHMIAS 727 BRAMAH N. SINGH AND
MICHAEL J. ANTONACCIO 47. CALCIUM CHANNEL BLOCKERS AND ADENOSINE AS
ANTIARRHYTHMIC DRUGS 747 BRAMAH N. SINGH VII. CONGESTIVE HEART FAILURE
48. CONGESTIVE HEART FAILURE: MECHANISMS, PHYSIOLOGIC DERANGEMENT, AND
THERAPY 765 GARY S. FRANCIS AND KENNETH M. MCDONALD 49. DIURETIC THERAPY
IN THE CONTROL OF HEART FAILURE 779 KANU CHATTERJEE 50. PRINCIPLES OF
VASODILATOR THERAPY IN CONGESTIVE HEART FAILURE: IMPACT ON MORTALITY 791
JAY N. COHN 51. ANGIOTENSIN-CONVERTING ENZYME INHIBITION IN HEART
FAILURE 797 GREGG C. FONAROW AND LYNNE WARNER STEVENSON 52. ARTERIOLAR
AND VENOUS VASODILATORS IN CONGESTIVE HEART FAILURE 815 JOSEPH A. GASCHO
AND ROBERT ZELIS 53. VASOSELECTIVE CALCIUM CHANNEL BLOCKERS IN
CONGESTIVE HEART FAILURE 827 CLAES HOFMAN-BANG AND LARS RYDEN 54.
PRINCIPLES OF INOTROPIC THERAPY IN HEART FAILURE 837 JEANNETTE L. YUEN,
EDMUND H. SONNENBLICK, AND THIERRY H. LEJEMTEL 55. CARDIAC GLYCOSIDES:
IMPACT ON MORTALITY 845 PHILIP POOLE-WILSON 56. P-ADRENERGIC BLOCKERS IN
HEART FAILURE 849 MICHAEL B. FOWLER VIII. HYPERTENSION 57.
PATHOPHYSIOLOGY OF HYPERTENSION AND TREATMENT 861 ALAN B. WEDER AND
STEVO JULIUS XX CONTENTS 58. DIURETICS IN HYPERTENSION 885 JULES B.
PUSCHETT 59. ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN THE TREATMENT
OF HYPERTENSION 909 BERNARD WAEBER, MICHEL BURNIER, AND HANS R. BRUNNER
60. CALCIUM CHANNEL BLOCKERS AS HYPOTENSIVE AGENTS 931 MICHAEL A. WEBER
AND WILLIAM F. GRAETTINGER 61. P-ADRENERGIC BLOCKERS IN THE TREATMENT OF
HYPERTENSION 945 GIULIANO FRANCA AND ALAN S. NIES 62. DRUGS ACTING AT
A-ADRENOCEPTORS: CENTRAL AND PERIPHERAL 957 DAVID ROBERTSON 63.
SEROTONIN ANTAGONISTS: KETANSERIN AND RITANSERIN*THEIR ROLE IN ARTERIAL
AND PORTAL HYPERTENSION 969 J. IAN S. ROBERTSON 64. EFFECTS OF
ANTIHYPERTENSIVE DRUGS ON ATHEROSCLEROSIS 987 VICTOR J. DZAU AND
NOWAMAGBE OMOIGUI 65. EFFECT OF ANTIHYPERTENSIVE THERAPY ON LEFT
VENTRICULAR HYPERTROPHY 999 BARRY M. MASSIE 66. THERAPY OF ORTHOSTATIC
HYPOTENSION 1015 DAVID ROBERTSON IX. DRUG THERAPY OF DYSLIPIDEMIAS AND
OF ATHEROSCLEROSIS 67. PLASMA LIPID TRANSPORT AND THE DEVELOPMENT OF
ATHEROSCLEROSIS 1025 WOLFGANG PATSCH AND ANTONIO M. GOTTO, JR. 68. AN
OVERVIEW OF LIPID-LOWERING TRIALS IN THEIR PHARMACOLOGIC AND BIOLOGIC
CONTEXTS 1043 JACQUES E. ROSSOUW 69. STRATEGIES AND IMPLEMENTATION OF
ANTIATHEROGENIC TREATMENT 1057 JOHN P. KANE AND MARY J. MALLOY 70.
PRINCIPLES AND GOALS OF HYPOLIPIDEMIC THERAPY 1067 DAVID A. LEAF AND
FRANKLIN L. MURPHY X. CARDIAC TRANSPLANTATION 71. CARDIAC
TRANSPLANTATION BIOLOGY: PHARMACOLOGY AND THERAPEUTICS 1091 SHARON A.
HUNT AND HANNAH A. VALANTINE XI. PHARMACOLOGY AND THERAPEUTICS DESERVING
SPECIAL CONSIDERATION 72. PHARMACOLOGY AND THERAPEUTICS IN PEDIATRIC
CARDIOLOGY 1099 THOMAS S. KLITZNER AND WILLIAM F. FRIEDMAN 73.
GERONTOLOGIC CONSIDERATIONS IN CARDIOVASCULAR PHARMACOLOGY AND
THERAPEUTICS 1127 KA KIT HUI 74. CARDIOVASCULAR DRUGS IN PREGNANCY AND
LACTATION 1143 JOSEF WIDERHORN, ARIE L.M. WIDERHORN, AND URI ELKAYAM 75.
EFFECT OF RACE ON CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTIC ACTIONS OF
DRUGS 1159 JOHN S. GOTTDIENER INDEX 1177
|
| any_adam_object | 1 |
| author_GND | (DE-588)143174428 |
| building | Verbundindex |
| bvnumber | BV009298461 |
| callnumber-first | R - Medicine |
| callnumber-label | RM345 |
| callnumber-raw | RM345 |
| callnumber-search | RM345 |
| callnumber-sort | RM 3345 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | XI 4300 |
| ctrlnum | (OCoLC)28748905 (DE-599)BVBBV009298461 |
| dewey-full | 615/.71 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.71 |
| dewey-search | 615/.71 |
| dewey-sort | 3615 271 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 1. publ. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02080nam a2200529 c 4500</leader><controlfield tag="001">BV009298461</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20161006 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">940331s1994 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0443088144</subfield><subfield code="9">0-443-08814-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)28748905</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV009298461</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM345</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.71</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 4300</subfield><subfield code="0">(DE-625)153005:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cardiovascular pharmacology and therapeutics</subfield><subfield code="c">ed. by Bramah N. Singh ...</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. publ.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">Churchill Livingstone</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XX, 1231 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Agents cardiovasculaires - Pharmacologie</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Agents cardiovasculaires - usage thérapeutique</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Farmacologie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Farmacotherapie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hartziekten</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Maladies cardiovasculaires - Traitement médicamenteux</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Maladies cardiovasculaires - physiopathologie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular Agents</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular Agents</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular Diseases</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular Diseases</subfield><subfield code="x">physiopathology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Heart</subfield><subfield code="x">Diseases</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kardiovaskuläres System</subfield><subfield code="0">(DE-588)4024665-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Kardiovaskuläres System</subfield><subfield code="0">(DE-588)4024665-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Singh, Bramah N.</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)143174428</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006187495&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006187495</subfield></datafield></record></collection> |
| id | DE-604.BV009298461 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:34:34Z |
| institution | BVB |
| isbn | 0443088144 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006187495 |
| oclc_num | 28748905 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-578 |
| owner_facet | DE-355 DE-BY-UBR DE-578 |
| physical | XX, 1231 S. Ill., graph. Darst. |
| publishDate | 1994 |
| publishDateSearch | 1994 |
| publishDateSort | 1994 |
| publisher | Churchill Livingstone |
| record_format | marc |
| spelling | Cardiovascular pharmacology and therapeutics ed. by Bramah N. Singh ... 1. publ. New York [u.a.] Churchill Livingstone 1994 XX, 1231 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Agents cardiovasculaires - Pharmacologie Agents cardiovasculaires - usage thérapeutique Farmacologie gtt Farmacotherapie gtt Hartziekten gtt Maladies cardiovasculaires - Traitement médicamenteux Maladies cardiovasculaires - physiopathologie Cardiovascular Agents pharmacology Cardiovascular Agents therapeutic use Cardiovascular Diseases drug therapy Cardiovascular Diseases physiopathology Cardiovascular agents Heart Diseases Treatment Kardiovaskuläres System (DE-588)4024665-6 gnd rswk-swf Pharmakologie (DE-588)4045687-0 gnd rswk-swf Kardiovaskuläres System (DE-588)4024665-6 s Pharmakologie (DE-588)4045687-0 s DE-604 Singh, Bramah N. Sonstige (DE-588)143174428 oth GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006187495&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Cardiovascular pharmacology and therapeutics Agents cardiovasculaires - Pharmacologie Agents cardiovasculaires - usage thérapeutique Farmacologie gtt Farmacotherapie gtt Hartziekten gtt Maladies cardiovasculaires - Traitement médicamenteux Maladies cardiovasculaires - physiopathologie Cardiovascular Agents pharmacology Cardiovascular Agents therapeutic use Cardiovascular Diseases drug therapy Cardiovascular Diseases physiopathology Cardiovascular agents Heart Diseases Treatment Kardiovaskuläres System (DE-588)4024665-6 gnd Pharmakologie (DE-588)4045687-0 gnd |
| subject_GND | (DE-588)4024665-6 (DE-588)4045687-0 |
| title | Cardiovascular pharmacology and therapeutics |
| title_auth | Cardiovascular pharmacology and therapeutics |
| title_exact_search | Cardiovascular pharmacology and therapeutics |
| title_full | Cardiovascular pharmacology and therapeutics ed. by Bramah N. Singh ... |
| title_fullStr | Cardiovascular pharmacology and therapeutics ed. by Bramah N. Singh ... |
| title_full_unstemmed | Cardiovascular pharmacology and therapeutics ed. by Bramah N. Singh ... |
| title_short | Cardiovascular pharmacology and therapeutics |
| title_sort | cardiovascular pharmacology and therapeutics |
| topic | Agents cardiovasculaires - Pharmacologie Agents cardiovasculaires - usage thérapeutique Farmacologie gtt Farmacotherapie gtt Hartziekten gtt Maladies cardiovasculaires - Traitement médicamenteux Maladies cardiovasculaires - physiopathologie Cardiovascular Agents pharmacology Cardiovascular Agents therapeutic use Cardiovascular Diseases drug therapy Cardiovascular Diseases physiopathology Cardiovascular agents Heart Diseases Treatment Kardiovaskuläres System (DE-588)4024665-6 gnd Pharmakologie (DE-588)4045687-0 gnd |
| topic_facet | Agents cardiovasculaires - Pharmacologie Agents cardiovasculaires - usage thérapeutique Farmacologie Farmacotherapie Hartziekten Maladies cardiovasculaires - Traitement médicamenteux Maladies cardiovasculaires - physiopathologie Cardiovascular Agents pharmacology Cardiovascular Agents therapeutic use Cardiovascular Diseases drug therapy Cardiovascular Diseases physiopathology Cardiovascular agents Heart Diseases Treatment Kardiovaskuläres System Pharmakologie |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006187495&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT singhbramahn cardiovascularpharmacologyandtherapeutics |